|
Real-time Estimate
Cboe Europe
18:57:01 03/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 119.80 SEK | +0.67% |
|
-3.47% | +12.52% |
| 03:41pm | BioGaia: Clinical study shows reduced infant colic after seven days | FW |
| 10-28 | Biogaia's Vice Chairman David Dangoor Sells Shares for SEK 19m | FW |
| Market Cap | 12.04B 1.23B 1.1B 1.01B 917M 1.72B 116B 1.75B 4.85B 61.47B 4.62B 4.52B 194B | P/E 2026 * |
29.8x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 11.36B 1.16B 1.04B 951M 865M 1.62B 110B 1.65B 4.58B 58B 4.36B 4.26B 183B | EV / Sales 2026 * |
6.72x | EV / Sales 2027 * | 5.94x |
| Free-Float |
80.82% | Yield 2026 * |
3.45% | Yield 2027 * | 3.68% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| BIOG B | Delayed | |
CBOE
| BIOGBs | Real-time | |
|
London S.E.
| 0GTN | Delayed | |
|
OTC Markets
| BGLAF | Delayed | |
|
Tradegate
| BGLA | Real-time | |
|
Deutsche Boerse AG
| BGLA | Delayed | |
|
CBOE
| 0GTN | Real-time | |
|
Börse Stuttgart
| BGLA | Delayed | |
|
Boerse Muenchen
| BGLA | Real-time |
Last Transcript: BioGaia AB
| 1 day | +0.67% | ||
| 1 week | -3.47% | ||
| Current month | -0.75% | ||
| 1 month | +3.73% | ||
| 3 months | +3.46% | ||
| Current year | +12.52% |
| 1 week | 117.5 |  | 123.8 |
| 1 month | 112.7 | | 135 |
| Current year | 97.5 | | 136.3 |
| 1 year | 96.2 | | 136.3 |
| 3 years | 93.2 | | 139.7 |
| 5 years | 68.88 | | 139.7 |
| 10 years | 52.2 | | 139.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Agnew
CEO | Chief Executive Officer | 60 | 30/09/2023 |
| Director of Finance/CFO | 59 | 05/11/2019 | |
Ludvig Milesson
COO | Chief Operating Officer | 49 | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Dangoor
CHM | Chairman | 77 | 01/01/2003 |
Anthon Jahreskog
BRD | Director/Board Member | 46 | 01/01/2015 |
| Director/Board Member | 40 | 01/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/02/26 | Buy | Director | 582 | 0.0006% | ||
| 30/12/25 | Buy | General Counsel | 390 | 0.0004% | ||
| 05/12/25 | Buy | Chief Financial Officer | 2,000 | 0.0020% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.67% | -3.47% | +18.79% | +15.91% | 1.23B | |
| +1.51% | +12.02% | +60.18% | +152.91% | 1,257B | |
| -0.26% | +0.29% | +44.69% | +78.08% | 651B | |
| +0.14% | +1.31% | +36.89% | +105.17% | 510B | |
| -0.37% | -0.55% | +52.91% | +67.25% | 388B | |
| -1.76% | +3.38% | +77.74% | +41.83% | 366B | |
| +0.75% | +2.94% | +33.23% | +59.06% | 303B | |
| +0.45% | +8.27% | +12.28% | +35.17% | 288B | |
| +0.21% | +4.05% | +57.31% | +72.72% | 252B | |
| +0.83% | +7.36% | +39.93% | +109.33% | 211B | |
| Average | +0.16% | +3.69% | +43.39% | +73.74% | 422.79B | |
| Weighted average by Cap. | +0.31% | +5.30% | +49.44% | +96.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.69B 173M 154M 141M 129M 241M 16.35B 246M 681M 8.63B 648M 634M 27.25B | 1.91B 195M 174M 160M 146M 273M 18.49B 278M 771M 9.76B 733M 718M 30.83B |
| Net income | 410M 41.95M 37.45M 34.37M 31.26M 58.61M 3.97B 59.78M 165M 2.1B 157M 154M 6.62B | 492M 50.23M 44.84M 41.15M 37.43M 70.18M 4.76B 71.58M 198M 2.51B 189M 184M 7.93B |
| Net Debt | -679M -69.39M -61.95M -56.85M -51.71M -96.95M -6.57B -98.89M -274M -3.47B -260M -255M -10.95B | -684M -69.9M -62.41M -57.27M -52.09M -97.67M -6.62B -99.61M -276M -3.49B -262M -257M -11.03B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/11/26 | SEK 119.50 | +0.42% | 63,269 |
| 02/11/26 | SEK 119.00 | -1.16% | 245,978 |
| 30/10/26 | SEK 120.40 | +0.42% | 85,049 |
| 29/10/26 | SEK 119.90 | -1.24% | 153,758 |
| 28/10/26 | SEK 121.40 | -1.94% | 342,624 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIOG B Stock
Select your edition
All financial news and data tailored to specific country editions
